Stamford, CT -- (SBWIRE) -- 09/24/2013 -- High Rising Stocks provides investors with the hottest penny stock alerts on a regular basis. Our Penny Stock Newsletter will send you alerts through our Free E Newsletters with High Yielding alerts, market forecasting, stock tips and strategies, and offer you the tools to help you along the way with the goal of keeping you loyal to our service. Today’s stocks to watch are: Titan Pharmaceuticals, Inc. (OTCBB:TTNP), Indo Global Exchange(s) PteLtd (OTCMKTS:IGEX), Media Analytics Corp (OTCBB:MEDA), Decision Diagnostics Corp (OTCBB:DECN)
Titan Pharmaceuticals, Inc. (OTCBB:TTNP) ended higher +3.36% and complete the day at $0.615. The total number of shares changed hands during the day was 292,659. After opening at $0.60, the stock hit as high as $0.62. However, it traded between $0.32 and $2.53 over the last twelve months. Titan Pharmaceuticals, Inc., a biopharmaceutical company, engages in developing proprietary therapeutics for the treatment of serious medical disorders in the United States. The company offers Fanapt (iloperidone), an atypical antipsychotic for the treatment of schizophrenia.
For How Long TTNP will Fight for Profitability? Read This Trend Analysis report
Indo Global Exchange(s) PteLtd (OTCMKTS:IGEX) closed yesterday at $0.635, a -6.62% decrease. Around 231,656 shares were traded, beating an-average trading volume of 114,945 shares. The company is now valued at around $46.03 million. Indo Global Exchange PTE LTD. offers an online global trading platform. The company was incorporated in 2012 and is based in Singapore.
Has IGEX Found The Bottom And Ready To Gain Momentum? Find Out Here
Media Analytics Corp (OTCBB:MEDA) moved -54.88 percent lower at $0.740 and traded between $0.68 and $1.67 after opening the day at $1.67. Its performance over the last five days remained -40.8%, which stands at -40.8% for a month. Going back further than one month, 1-year performance after recent close was -40.8%. FanSport, Inc., a development stage company, focuses on developing and providing social gaming mobile applications for fantasy sports enthusiasts. The company?s software solutions would enable its customers to draft, trade, and track their sports fantasy leagues on their phones.
Why Should Investors Buy MEDA After the Recent Fall? Just Go Here and Find Out
Decision Diagnostics Corp (OTCBB:DECN)’s shares rose, +11.27 percent to close at $0.790. The stock is up around +295% this year and +690% for the last 12 months. Around 564,383 shares changed hands yesterday, higher from an-average trading volume of 288,995 shares. Decision Diagnostics Corp. distributes prescription and non-prescription diagnostics, and home testing products in the United States. The company provides bulk prescription drugs on a wholesale basis; and distributes diabetes diagnostics and supplies. It also offers ostomy, wound care, and post-surgery medical products.
Why Should Investors Buy DECN After The Recent Gain? Just Go Here and Find Out
High Rising Stocks is always searching the market every day for massive penny stock runs before they happen so you don't have to.We will send you alerts through our Free E Newsletters with High Yielding alerts, market forecasting, stock tips and strategies, and offer you the tools to help you along the way with the goal of keeping you loyal to our service.
Carriage Consulting Group, High Rising Stocks, their Members, officers, directors, employees, affiliates, or any other related person(s) (collectively, “High Rising Stocks”) are not registered as a securities broker-dealer or an investment adviser either with the U.S. Securities and Exchange Commission (the “SEC”) or with any state securities regulatory authority. High Rising Stocks as defined are neither licensed nor qualified to provide investment advice and you are specifically and adamantly advised not to rely upon anything said/posted/communicated/implied or expressed by High Rising Stocks as defined.
Read full Disclaimer at: http://highrisingstocks.com/disclaimer/
Copyright © 2005-2013 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)